Published in Neurology on January 08, 2002
Management Of Acute Disseminating Encephalomyelitis | NCT03284801
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med (2005) 10.39
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol (2010) 3.28
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain (2008) 3.05
Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest (2006) 2.75
Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol (2013) 1.79
Acute disseminated encephalomyelitis. Postgrad Med J (2003) 1.73
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica. PLoS One (2010) 1.68
Cyclophosphamide therapy in pediatric multiple sclerosis. Neurology (2009) 1.62
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Rev Neurol (2014) 1.53
Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol (2011) 1.49
Complement in multiple sclerosis: its role in disease and potential as a biomarker. Clin Exp Immunol (2008) 1.17
Idiopathic inflammatory-demyelinating diseases of the central nervous system. Neuroradiology (2007) 1.16
Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica. PLoS One (2011) 1.13
New insights into neuromyelitis optica. J Clin Neurol (2011) 1.09
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain (2012) 1.06
Treatment of acute relapses in multiple sclerosis. Neurotherapeutics (2013) 1.05
Acute disseminated encephalomyelitis: Treatment guidelines. Ann Indian Acad Neurol (2011) 1.04
Infection-associated encephalopathies: their investigation, diagnosis, and treatment. J Neurol (2006) 1.03
Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels. J Clin Neurol (2013) 1.01
Brain-reactive antibodies and disease. Annu Rev Immunol (2013) 0.94
Neuromyelitis Optica. Curr Treat Options Neurol (2005) 0.93
Current options for the treatment of optic neuritis. Clin Ophthalmol (2012) 0.92
Plasma exchange in episodes of severe inflammatory demyelination of the central nervous system. A report of six cases. J Neurol (2004) 0.92
Neuromyelitis optica - an update: 2007-2009. Ann Indian Acad Neurol (2009) 0.92
Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices. Curr Neuropharmacol (2011) 0.91
Plasma exchange in severe attacks of neuromyelitis optica. Mult Scler Int (2012) 0.90
Immunology of neuromyelitis optica: a T cell-B cell collaboration. Ann N Y Acad Sci (2013) 0.89
Neuromyelitis optica and anti-aquaporin-4 antibodies: widening the clinical phenotype. J Neurol Neurosurg Psychiatry (2006) 0.89
Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei. Schizophr Res (2007) 0.89
The role of plasmapheresis in critical illness. Crit Care Clin (2012) 0.88
Escalating immunotherapy of multiple sclerosis--new aspects and practical application. J Neurol (2004) 0.88
Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome. J Neurol (2015) 0.86
Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. Arch Neurol (2009) 0.86
Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients. PLoS One (2015) 0.84
The treatment of neuromyelitis optica. J Neuroophthalmol (2014) 0.84
Escalating immunotherapy of multiple sclerosis. Ther Adv Neurol Disord (2008) 0.84
Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases. Indian J Hematol Blood Transfus (2016) 0.84
Plasma Exchange in a Patient with Tumefactive, Corticosteroid-Resistant Multiple Sclerosis. Int J MS Care (2015) 0.83
Refractory Fulminant Acute Disseminated Encephalomyelitis (ADEM) in an Adult. Front Neurol (2014) 0.82
Immunotherapy of neuromyelitis optica. Autoimmune Dis (2013) 0.81
Successful treatment of a hypothalamic lesion in neuromyelitis optica by plasma exchange. J Neurol (2007) 0.80
Plasma exchange therapy for steroid-refractory superimposed relapses in secondary progressive multiple sclerosis. J Neurol (2007) 0.80
The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data. Hum Vaccin Immunother (2015) 0.80
Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens. J Neuroimmunol (2007) 0.80
Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study. J Neurol (2016) 0.80
Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis. Neurohospitalist (2013) 0.78
Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis. Neurol Res Int (2011) 0.78
Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder. Ann Lab Med (2012) 0.78
Multiple sclerosis therapy: an update on recently finished trials. J Neurol (2007) 0.78
Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implications. Ther Adv Neurol Disord (2010) 0.77
Therapeutics to promote CNS repair: a natural human neuron-binding IgM regulates membrane-raft dynamics and improves motility in a mouse model of multiple sclerosis. J Clin Immunol (2012) 0.77
Extensive acute disseminated encephalomyelitis in a young girl responding to intravenous methylprednisolone. BMJ Case Rep (2013) 0.77
In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica-related pathology. Ann Neurol (2016) 0.77
Cerebral tumefactive demyelinating lesions. Oncol Lett (2015) 0.77
Plasma exchange for steroid unresponsive Devic's disease. Indian J Nephrol (2012) 0.75
How to run a multiple sclerosis relapse clinic. Pract Neurol (2015) 0.75
Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis. Neuropsychiatr Dis Treat (2007) 0.75
Cyclosporine in the treatment of a case of fulminant and refractory acute disseminated encephalomyelitis. Iran J Pediatr (2011) 0.75
Enhancing Brain Lesions during Acute Optic Neuritis and/or Longitudinally Extensive Transverse Myelitis May Portend a Higher Relapse Rate in Neuromyelitis Optica Spectrum Disorders. AJNR Am J Neuroradiol (2017) 0.75
[A treatment of neuromyelitis optica (Devic's disease) during pregnancy]. Pan Afr Med J (2016) 0.75
Reversible stenosis of large cerebral arteries in a patient with combined Sjögren's syndrome and neuromyelitis optica spectrum disorder. Rheumatol Int (2008) 0.75
Improving outcomes in multiple sclerosis through early diagnosis and effective management. Prim Care Companion CNS Disord (2012) 0.75
Plasmapheresis: are bigger studies necessarily better? Nat Rev Neurol (2012) 0.75
[Current recommendations on optic neuritis]. Ophthalmologe (2014) 0.75
Role of low plasma volume treatment on clinical efficacy of plasmapheresis in neuromyelitis optica. Asian J Transfus Sci (2017) 0.75
Plasma exchange response in 34 patients with severe optic neuritis. J Neurol (2016) 0.75
Optic neuritis as an early sign of multiple sclerosis. Eye Brain (2016) 0.75
Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57
Multiple sclerosis. N Engl J Med (2000) 12.69
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol (2000) 9.73
The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03
OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet (2000) 7.20
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
Trauma and multiple sclerosis: a population-based cohort study from Olmsted County, Minnesota. Neurology (1993) 4.04
Potential effect of authorization bias on medical record research. Mayo Clin Proc (1999) 4.01
Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol (1992) 3.53
Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology (2009) 3.43
Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis (2001) 3.42
Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology (2011) 3.30
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology (2008) 3.21
Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment. AJNR Am J Neuroradiol (2010) 3.03
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol (2012) 2.96
Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk. Lancet (1992) 2.69
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69
A mutation in the voltage-gated sodium channel gene associated with pyrethroid resistance in Latin American Aedes aegypti. Insect Mol Biol (2007) 2.60
Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol (1983) 2.60
Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest (1999) 2.51
Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci (1997) 2.44
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol (1996) 2.41
Health care utilization in multiple sclerosis: a population-based study in Olmsted County, MN. Neurology (1998) 2.38
Review of psychosocial stress and asthma: an integrated biopsychosocial approach. Thorax (1998) 2.33
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology (2007) 2.32
Remote cerebellar hemorrhage after supratentorial surgery. Neurosurgery (2001) 2.30
Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology (1998) 2.26
Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25
Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew. Psychosom Med (1997) 2.19
Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med (1986) 2.18
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
CNS aquaporin-4 autoimmunity in children. Neurology (2008) 2.10
White-light filaments for atmospheric analysis. Science (2003) 2.07
How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial. Rheumatology (Oxford) (2004) 2.06
Regulating the interpersonal self: strategic self-regulation for coping with rejection sensitivity. J Pers Soc Psychol (2000) 2.05
Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem (1994) 2.04
Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J Immunol (1985) 1.98
Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology. Anesth Analg (1989) 1.96
Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys (1994) 1.94
Involvement of pp60c-src with two major signaling pathways in human breast cancer. Proc Natl Acad Sci U S A (1994) 1.94
Virus-induced alterations in homeostasis: alteration in differentiated functions of infected cells in vivo. Science (1982) 1.88
Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol Cell Neurosci (1998) 1.78
Multifocal inflammatory leukoencephalopathy associated with levamisole therapy. Neurology (1995) 1.76
A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology (2007) 1.70
The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain (2001) 1.70
A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (1994) 1.68
A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology (1990) 1.66
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab (2008) 1.66
Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney Int (2007) 1.65
Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology (2011) 1.64
A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain (1999) 1.63
Antimitochondrial antibodies in jaundice following drug administration. JAMA (1969) 1.61
Okadaic acid, a protein phosphatase inhibitor, blocks calcium changes, gene expression, and cell death induced by gibberellin in wheat aleurone cells. Plant Cell (1996) 1.56
Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology (2003) 1.56
Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin. Eur J Neurol (2010) 1.55
Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology (1986) 1.55
Engineering a homo-ethanol pathway in Escherichia coli: increased glycolytic flux and levels of expression of glycolytic genes during xylose fermentation. J Bacteriol (2001) 1.55
A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet (2000) 1.54
The efficacy of epidural blood patch in spontaneous CSF leaks. Neurology (2001) 1.54
Strains from both Theiler's virus subgroups encode a determinant for demyelination. J Virol (1990) 1.53
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int (2007) 1.53
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology (2008) 1.53
Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis. Mayo Clin Proc (1992) 1.53
Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology (2004) 1.51
Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus. J Virol (1991) 1.50
Teaching community-oriented primary care through longitudinal group projects. Fam Med (1998) 1.50
Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J Immunol (1989) 1.49
Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A (2000) 1.46
A window of opportunity for no treatment in early multiple sclerosis? Mult Scler (2010) 1.45
Complete ophthalmoplegia as a complication of acute corticosteroid- and pancuronium-associated myopathy. Neurology (1991) 1.44
Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis. Ann Neurol (1992) 1.44
The influence of acute and chronic hypercalcemia on the parathyroid hormone response to hypocalcemia in rabbits. Eur J Endocrinol (2002) 1.44
Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management. Acta Cytol (1999) 1.43
Human T-cell lymphotropic virus type I sequences detected by nested polymerase chain reactions are not associated with multiple sclerosis. Mayo Clin Proc (1991) 1.43
Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 1.42
Therapeutic plasma exchange: a paired comparison of Fresenius AS104 vs. COBE Spectra. J Clin Apher (2001) 1.41
Screening digital rectal examination and prostate cancer mortality: a population-based case-control study. Urology (1998) 1.41
Relationship of dietary intake to subsequent coronary heart disease incidence: The Puerto Rico Heart Health Program. Am J Clin Nutr (1980) 1.40
HTLV-1 associated myelopathy in Canada. Can J Neurol Sci (1989) 1.40
Plateletapheresis with a next generation blood cell separator. J Clin Apher (1997) 1.39
An ideR mutant of Mycobacterium smegmatis has derepressed siderophore production and an altered oxidative-stress response. Mol Microbiol (1996) 1.39
The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (1999) 1.38
[Is aggressiveness really inhibited in asthmatic adolescents? An epidemiological approach]. Rev Mal Respir (2001) 1.38
Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV). Am J Pathol (1983) 1.37
Variability of fish consumption within the 10 European countries participating in the European Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr (2002) 1.35
Neonatal infection with the Daniels strain of Theiler's murine encephalomyelitis virus. Lab Invest (1983) 1.34
Literacy promotion for Hispanic families in a primary care setting: a randomized, controlled trial. Pediatrics (1999) 1.33
Transfusion reactions associated with anti-IgA antibodies: report of four cases and review of the literature. Transfusion (1975) 1.32
Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer (2012) 1.32
Hemolytic transfusion reaction. Recent experience in a large blood bank. Mayo Clin Proc (1978) 1.31
Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry (2006) 1.31
Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry (2010) 1.30